Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2004

View Archived Issues

No difference in risks with tamoxifen use between African American and white breast cancer patients

Significant relief achieved with octreotide in cluster headache patients

Novel PDE5 inhibitor from Fujisawa

Aromatase inhibitor reduces seizure rate in male patients with partial epilepsy

Clinical benefits of liposteroid therapy in West syndrome patients

Significant pain relief achieved with levetiracetam in trigeminal neuralgia

Improved glycemic control achieved with insulin glulisine in type 2 diabetes

Enrollment completed in SAINT I study of Cerovive in stroke patients

Wyeth responds to U.K. MHRA's action on Efexor

U.S. launch of DepoDur

Myriad files IND for phase I study of MPC-6827

Serono and Micromet sign collaboration and license agreement for MT-201

FAST phase II/III study completed for Fibrillex

Recordati seeks German approval of fixed combination product for hypertension

Intravenous Boniva submitted for FDA approval

Swiss clearance for phase I study of 1D09C3

Nabi eyes StaphVAX filings in Europe and U.S.

Topigen to conduct pilot study of potential asthma treatment ASM-8

PTC-124 awarded orphan drug status for cystic fibrosis

Immune Response Corporation expands MS development program

Final phase II results confirm the efficacy of telavancin in cSSSI

Enrollment open in phase Ib study of ARQ-501 and Taxotere

Update on the safety and antiepileptic effects of UCB-34714

Enrollment under way in pivotal MS study of MBP-8298

Palatin reports new agents for the treatment of obesity

Novel opioid receptor antagonists emerge from Pfizer R&D

Dabur researchers describe anticancer compounds

Janssen claims antiinflammatory phospholipase C inhibitors in patent

New beta-lactamase inhibitors designed by Wyeth researchers

Roche claims CRF receptor antagonists and their use in stress-related disorders, anxiety, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...